On Monday, July 31st, the FDA announced the decision to re-evaluate their policy concerning the morning-after pill. Currently, distribution of the morning-after pill over the counter has been blocked mainly for political reasons as opposed to realistic medical reasons. The FDA is reconsidering this position and according to NARAL, this change of agenda is due to over 40,000 complaints voiced by the public. The catch of course is, the agency has not disclosed when if any alterations in the policy will happen.
Please take the time to send a quick message to acting commissioner, Andrew Von Eschenbach via NARAL,to take action.
Technorati: activism, NARAL, FDA, Morning After Pill